Cosentyx first Interleukin-17A inhibitor for psoriatic arthritis and ankylosing spondylitis approved by Health CanadaRead
A multifaceted approach for the early clinical identification of axial spondyloarthritis: a study of first degree relativesRead
AS Health Storylines Mobile App, Self-care for Ankylosing Spondylitis and associated Spondyloarthritis diseasesRead
A Canadian research team (including patients, healthcare providers, researchers and policy makers) is exploring new ways to help people with chronic illness live well.Read
Join our mailing list and be the first to hear about news, events and research.